Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) was $12.90 for the day, up 11.40% from the previous closing price of $11.58. In other words, the price has increased by $11.40 from its previous closing price. On the day, 1.98 million shares were traded. DNA stock price reached its highest trading level at $13.05 during the session, while it also had its lowest trading level at $11.66.
Ratios:
Our analysis of DNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.56.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 22 ’25 when Che Austin bought 99 shares for $11.65 per share.
Che Austin bought 99 shares of DNA for $1,090 on Jan 21 ’25. On Jan 17 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $10.31 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 741477760 and an Enterprise Value of 532155872. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.40 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 2.442 whereas that against EBITDA is -1.012.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $64.40, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is 37.85%, while the 200-Day Moving Average is calculated to be -14.96%.
Shares Statistics:
DNA traded an average of 1.31M shares per day over the past three months and 1292180 shares per day over the past ten days. A total of 41.37M shares are outstanding, with a floating share count of 36.49M. Insiders hold about 33.02% of the company’s shares, while institutions hold 47.75% stake in the company. Shares short for DNA as of 1735603200 were 7374291 with a Short Ratio of 5.61, compared to 1732838400 on 7415212. Therefore, it implies a Short% of Shares Outstanding of 7374291 and a Short% of Float of 22.15.
